Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 27 Breast Neoplasms 19 Fallopian Tube Neoplasms 18 Multiple Myeloma 14 Carcinoma, Ovarian Epithelial 12 Lymphoma 7 Triple Negative Breast Neoplasms 4 Neoplasms, Plasma Cell 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡